BARNASCAN ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
88慢性血栓塞栓性肺高血圧症1

88. 慢性血栓塞栓性肺高血圧症


臨床試験数 : 157 薬物数 : 107 - (DrugBank : 22) / 標的遺伝子数 : 14 - 標的パスウェイ数 : 54
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2016-000347-14-ES
(EUCTR)
16/06/201617/05/2016Comparative study between patients with pulmonary hypertension and healthy subjects detecting pulmonary cell changes by FDG PET imagingCell proliferation in pulmonary hypertension: mollecular imaging detection by FDG PET. Comparative study between patients and healthy subjects Pulmonary artery hypertension and thromboembolic chronic pulmonary hypertension
MedDRA version: 19.0;Level: LLT;Classification code 10037405;Term: Pulmonary hypertension primary;System Organ Class: 100000004855
MedDRA version: 19.0;Classification code 10068739;Term: Chronic thromboembolic pulmonary hypertension;System Organ Class: 100000004855;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
Trade Name: Barnascan
Product Name: BARNASCAN
INN or Proposed INN: FLUDEOXYGLUCOSE
Other descriptive name: FLUDEOXYGLUCOSE
IDIBAPSNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
Phase 2Spain